PARDES BIOSCIENCES, INC

Profile

Company Names

PARDES BIOSCIENCES, INC

Addresses

2173 SALK AVE., SUITE 250, PMB #052, CARLSBAD, CA 92008

Phone Numbers

415-649-8758

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$51,614,997.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-01-19 
$51,614,997.00 
$51,614,997.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEE 
 
ARNOLD 
EXECUTIVE OFFICER
SECURED INVESTMENT HIGH YIELD FUND, LLC   |  SECURED INVESTMENT HIGH YIELD FUND II, LLC   |  PARDES BIOSCIENCES, INC
MARK 
 
AUEURBACH 
DIRECTOR
PARDES BIOSCIENCES, INC
HEIDI 
 
HENSON 
EXECUTIVE OFFICER
ARAXES PHARMA, LLC   |  KURA ONCOLOGY, INC.   |  KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  PARDES BIOSCIENCES, INC   |  PEPGEN INC.   |  PERSPECTIVE THERAPEUTICS, INC.
ELIZABETH 
 
LACY 
EXECUTIVE OFFICER
PARDES BIOSCIENCES, INC
J. JAY 
 
LOBELL 
DIRECTOR
PARDES BIOSCIENCES, INC
URI 
A. 
LOPTAIN 
EXECUTIVE OFFICER, DIRECTOR
PARDES BIOSCIENCES, INC
JAMES 
B. 
TANANBAUM 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  PATHWORK DIAGNOSTICS INC   |  FORESITE CAPITAL II-AA, LLC   |  FORESITE CAPITAL IV-C, LLC   |  FORESITE CAPITAL FUND II, L.P.   |  PARDES BIOSCIENCES, INC   |  ALUMIS INC.
MICHAEL 
D. 
VARNEY 
DIRECTOR
PARDES BIOSCIENCES, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#